Characteristics | Avg. ± SD (Min.–Max.), number |
---|---|
Age | 47.5 ± 6.1 (35–81), n = 323 |
Body mass index (kg/m2) | 22.9 ± 3.7 (15.9–37.8), n = 323 |
Parity | 1.2 ± 1.0 (0–4), n = 323 |
Hospitalization duration (days) | 6.4 ± 2.2 (5–40), n = 323 |
Operation time (min) | 206.8 ± 57.2 (94–504), n = 323 |
Concomitant procedure | 261.5 ± 44.1 (163–359), n = 44 |
No concomitant procedure | 198.2 ± 54.2 (94–504), n = 279 |
Blood loss (ml) | 132.4 ± 196.8 (0–1500), n = 323 |
Concomitant procedure | 164.9 ± 221.3 (0–1150), n = 44 |
No concomitant procedure | 127.3 ± 192.6 (0–1500), n = 279 |
Weight of resected uterus (g) | 296.7 ± 206.3 (42–1284), n = 320 |
Size of uterus (TVUS) (mm) | 73.3 ± 20.1 (29–155), n = 323 |
Size of dominant leiomyoma (MRI) (mm) | 62.4 ± 29.2 (15–176), n = 276 |
Size of dominant leiomyoma (TVUS) (mm) | 56.2 ± 23.6 (13–130), n = 266 |
Haemoglobin concentration (mIU/ml) | |
Before operation | 13.0 ± 1.2 (6.6–16.7), n = 323 |
Immediately after operation | 11.2 ± 1.3 (6.7–15.0), n = 323 |
Before discharge | 11.3 ± 1.3 (7.9–15.5), n = 322 |
Gynaecological surgical history | n = 66 |
Symptomatic patients | n = 280 |
Hypermenorrhoea | n = 151 |
Prolonged menstruation | n = 15 |
Dysmenorrhoea | n = 39 |
Abnormal vaginal bleeding | n = 59 |
Anaemia | n = 111 |
Abdominal compression | n = 25 |
Abdominal pain | n = 35 |
Urination/defecation disorder | n = 22 |
Asymptomatic patients | n = 143 |
Notable findings (on MRI) | |
Submucous leiomyoma | n = 70 |
Adenomyoma | n = 77 |
Ovarian tumour | n = 40 |
Autologous blood donation | n = 230 |
Blood transfusion | n = 20 |
Autologous blood transfusion | n = 19 |
Allogeneic blood transfusion | n = 1 |
Annual number of TLHs | |
2015 | n = 24 |
2016 | n = 32 |
2017 | n = 75 |
2018 | n = 106 |
2019 | n = 86 |